In contrast to findings with behavioral 20,21,22 and other pharmacological interventions 10,12,13 , the similar mean weight loss achieved with semaglutide 2.4 mg in STEP 5 at weeks 52 and 104 (15.6% and 15.2%, respectively) suggests that, on average, there is minimal weight regain over 104 weeks when once-weekly semaglutide therapy is continued
That one drug might offer a greater degree of weight loss doesnt diminish the effect of the other and, even if it did, persistent supply shortages for both products mean the market would likely still welcome a similar, if inferior, product
It manages hot flashes, vaginal atrophy, mood, bone density, and cardiovascular markers tied to estrogen status
What Are GLP-1 Medications & Why Do They Work
Weeks later, Lilly responded, once again cutting the price of its GLP-1 weight loss option, Zepbound, when purchased through the direct-to-consumer platform LillyDirect
Nature 562 (7727), 367372